- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the China In Vitro Diagnostics (IVD) market.
- Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the China In Vitro Diagnostics (IVD) competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 16
2.1 What is This Report About? 16
3 In Vitro Diagnostics In China 17
3.1 In Vitro Diagnostics, Market Segmentation 17
3.2 In Vitro Diagnostics, China, Overall Revenue ($m), 2002-2016 18
3.3 In Vitro Diagnostics Market, China, Revenue Mix ($m), 2009 20
3.4 In Vitro Diagnostics Market, China, Category Contribution (%), 2009 21
3.5 In Vitro Diagnostics, China, Company Share (2008-2009) 27
4 Clinical Chemistry In China 28
4.1 Clinical Chemistry, Market Segmentation 28
4.2 Clinical Chemistry Market, China, Revenue Mix ($m), 2009 29
4.3 Clinical Chemist
Copyright©2010 PR Newswire.
All rights reserved